Download PDF
Clin Colon Rectal Surg 2010; 23(3): 142-148
DOI: 10.1055/s-0030-1262981
© Thieme Medical Publishers

Metabolic Support of the Enterocutaneous Fistula Patient

Joshua I. S. Bleier1 , Traci Hedrick2
  • 1Department of Surgery, Division of Colorectal Surgery, Pennsylvania Hospital/Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
  • 2Department of Surgery, University of Virginia, Charlottesville, Virginia
Further Information

Publication History

Publication Date:
24 August 2010 (online)

    Permissions and Reprints

ABSTRACT

Enterocutaneous fistula (ECF) is a challenging clinical problem with many etiologies; however, the most common cause is iatrogenic, complicating abdominal surgery. Advances in the overall care of the ECF patient have resulted in dramatic reductions in morbidity and mortality over the last five decades. A structured approach to the management of ECF has been shown to result in improved outcomes. Initial physiologic stabilization of the postoperative patient, focused on hemodynamic and fluid support as well as aggressive sepsis control are the critical initial maneuvers. Subsequent optimization of nutrition and wound care allows the patient to regain a positive nitrogen balance, and allow for healing. Judicious use of antimotility agents as well as advanced wound care techniques helps to maximize healing as well as quality of life, and prepare patients for subsequent definitive surgery.

KEYWORDS

Enterocutaneous fistula - nutrition - parenteral - metabolic support

REFERENCES

  • 1 Irving M, White R, Tresadern J. Three years' experience with an intestinal failure unit.  Ann R Coll Surg Engl. 1985;  67(1) 2-5
    PubMedGoogle Scholar
  • 2 Draus Jr J M, Huss S A, Harty N J, Cheadle W G, Larson G M. Enterocutaneous fistula: are treatments improving?.  Surgery. 2006;  140(4) 570-576 discussion 576-578
    CrossrefPubMedGoogle Scholar
  • 3 Visschers R G, Olde Damink S W, van Bekkum M, Winkens B, Soeters P B, van Gemert W G. Health-related quality of life in patients treated for enterocutaneous fistula.  Br J Surg. 2008;  95(10) 1280-1286
    CrossrefPubMedGoogle Scholar
  • 4 Teixeira P G, Inaba K, Dubose J et al.. Enterocutaneous fistula complicating trauma laparotomy: a major resource burden.  Am Surg. 2009;  75(1) 30-32
    PubMedGoogle Scholar
  • 5 Trzeciak S, Dellinger R P, Abate N L et al.. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department.  Chest. 2006;  129(2) 225-232
    CrossrefPubMedGoogle Scholar
  • 6 Dellinger R P, Levy M M, Carlet J M International Surviving Sepsis Campaign Guidelines Committee et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.  Crit Care Med. 2008;  36(1) 296-327
    CrossrefPubMedGoogle Scholar
  • 7 Solomkin J S, Mazuski J E, Bradley J S et al.. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.  Clin Infect Dis. 2010;  50(2) 133-164
    CrossrefPubMedGoogle Scholar
  • 8 Berry S M, Fischer J E. Enterocutaneous fistulas.  Curr Probl Surg. 1994;  31(6) 469-566
    PubMedGoogle Scholar
  • 9 Hedrick T L, Evans H L, Smith R L et al.. Can we define the ideal duration of antibiotic therapy?.  Surg Infect (Larchmt). 2006;  7(5) 419-432
    CrossrefPubMedGoogle Scholar
  • 10 Joyce M R, Dietz D W. Management of complex gastrointestinal fistula.  Curr Probl Surg. 2009;  46(5) 384-430
    CrossrefPubMedGoogle Scholar
  • 11 Schecter W P, Hirshberg A, Chang D S et al.. Enteric fistulas: principles of management.  J Am Coll Surg. 2009;  209(4) 484-491
    CrossrefPubMedGoogle Scholar
  • 12 Goverman J, Yelon J A, Platz J J, Singson R C, Turcinovic M. The “fistula VAC,” a technique for management of enterocutaneous fistulae arising within the open abdomen: report of 5 cases.  J Trauma. 2006;  60(2) 428-431 discussion 431
    CrossrefPubMedGoogle Scholar
  • 13 Gunn L A, Follmar K E, Wong M S, Lettieri S C, Levin L S, Erdmann D. Management of enterocutaneous fistulas using negative-pressure dressings.  Ann Plast Surg. 2006;  57(6) 621-625
    CrossrefPubMedGoogle Scholar
  • 14 Cro C, George K J, Donnelly J, Irwin S T, Gardiner K R. Vacuum assisted closure system in the management of enterocutaneous fistulae.  Postgrad Med J. 2002;  78(920) 364-365
    CrossrefPubMedGoogle Scholar
  • 15 Wainstein D E, Fernandez E, Gonzalez D, Chara O, Berkowski D. Treatment of high-output enterocutaneous fistulas with a vacuum-compaction device. A ten-year experience.  World J Surg. 2008;  32(3) 430-435
    CrossrefPubMedGoogle Scholar
  • 16 Fischer J E. A cautionary note: the use of vacuum-assisted closure systems in the treatment of gastrointestinal cutaneous fistula may be associated with higher mortality from subsequent fistula development.  Am J Surg. 2008;  196(1) 1-2
    CrossrefPubMedGoogle Scholar
  • 17 Bee T K, Croce M A, Magnotti L J et al.. Temporary abdominal closure techniques: a prospective randomized trial comparing polyglactin 910 mesh and vacuum-assisted closure.  J Trauma. 2008;  65(2) 337-342 discussion 342-344
    CrossrefPubMedGoogle Scholar
  • 18 Visschers R G, Olde Damink S W, Winkens B, Soeters P B, van Gemert W G. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas.  World J Surg. 2008;  32(3) 445-453
    CrossrefPubMedGoogle Scholar
  • 19 Dudrick S J, Maharaj A R, McKelvey A A. Artificial nutritional support in patients with gastrointestinal fistulas.  World J Surg. 1999;  23(6) 570-576
    CrossrefPubMedGoogle Scholar
  • 20 Chapman R, Foran R, Dunphy J E, Foran R, Dunphy J E. Management of intestinal fistulas.  Am J Surg. 1964;  108 157-164
    CrossrefPubMedGoogle Scholar
  • 21 Lloyd D A, Gabe S M, Windsor A C. Nutrition and management of enterocutaneous fistula.  Br J Surg. 2006;  93(9) 1045-1055
    CrossrefPubMedGoogle Scholar
  • 22 Stanga Z, Brunner A, Leuenberger M et al.. Nutrition in clinical practice-the refeeding syndrome: illustrative cases and guidelines for prevention and treatment.  Eur J Clin Nutr. 2008;  62(6) 687-694
    CrossrefPubMedGoogle Scholar
  • 23 Paauw J D, Borders H, Ingalls N et al.. The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants.  JPEN J Parenter Enteral Nutr. 2008;  32(4) 443-447
    CrossrefPubMedGoogle Scholar
  • 24 Marra A R, Opilla M, Edmond M B, Kirby D F. Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition.  J Clin Gastroenterol. 2007;  41(1) 19-28
    CrossrefPubMedGoogle Scholar
  • 25 Fiel M I, Wu H S, Iyer K, Rodriguez-Laiz G, Schiano T D. Rapid reversal of parenteral-nutrition-associated cirrhosis following isolated intestinal transplantation.  J Gastrointest Surg. 2009;  13(9) 1717-1723
    CrossrefPubMedGoogle Scholar
  • 26 Bower R H, Cerra F B, Bershadsky B et al.. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial.  Crit Care Med. 1995;  23(3) 436-449
    CrossrefPubMedGoogle Scholar
  • 27 Schilling J, Vranjes N, Fierz W et al.. Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions.  Nutrition. 1996;  12(6) 423-429
    CrossrefPubMedGoogle Scholar
  • 28 Heyland D K, Novak F, Drover J W, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence.  JAMA. 2001;  286(8) 944-953
    CrossrefPubMedGoogle Scholar
  • 29 Marik P E, Zaloga G P. Immunonutrition in critically ill patients: a systematic review and analysis of the literature.  Intensive Care Med. 2008;  34(11) 1980-1990
    CrossrefPubMedGoogle Scholar
  • 30 Lévy E, Frileux P, Cugnenc P H, Honiger J, Ollivier J M, Parc R. High-output external fistulae of the small bowel: management with continuous enteral nutrition.  Br J Surg. 1989;  76(7) 676-679
    CrossrefPubMedGoogle Scholar
  • 31 Teubner A, Morrison K, Ravishankar H R, Anderson I D, Scott N A, Carlson G L. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula.  Br J Surg. 2004;  91(5) 625-631
    CrossrefPubMedGoogle Scholar
  • 32 Nubiola-Calonge P, Badía J M, Sancho J, Gil M J, Segura M, Sitges-Serra A. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output.  Lancet. 1987;  2(8560) 672-674
    PubMedGoogle Scholar
  • 33 Scott N A, Finnegan S, Irving M H. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study.  Acta Gastroenterol Belg. 1993;  56(3-4) 266-270
    PubMedGoogle Scholar
  • 34 Sancho J J, di Costanzo J, Nubiola P et al.. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula.  Br J Surg. 1995;  82(5) 638-641
    CrossrefPubMedGoogle Scholar
  • 35 Alvarez C, McFadden D W, Reber H A. Complicated enterocutaneous fistulas: failure of octreotide to improve healing.  World J Surg. 2000;  24(5) 533-537 discussion 538
    CrossrefPubMedGoogle Scholar
  • 36 Alivizatos V, Felekis D, Zorbalas A. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas.  Hepatogastroenterology. 2002;  49(46) 1010-1012
    PubMedGoogle Scholar

Joshua I. S BleierM.D. 

Department of Surgery, Division of Colorectal Surgery, Pennsylvania Hospital/Hospital of the University of Pennsylvania

700 Spruce St., Ste. 305, Philadelphia, PA 19106

Email: joshua.bleier@uphs.upenn.edu

      >